A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits

Vaccine

Volumn 31, Issue 28, 2013, Pages 2963-2971

  Kuschner, Robert A ^a   Russell, Kevin L ^b   Abuja, Mary ^b   Bauer, Kristen M ^a   Faix, Dennis J ^b   Hait, Howard ^c   Henrick, Jennifer ^c   Jacobs, Michael ^d   Liss, Alan ^c   Lynch, Julia A ^a   Liu, Qi ^e   Lyons, Arthur G ^a   Malik, Mohammad ^d   Moon, James E ^a   Stubbs, Jeremiah ^a   Sun, Wellington ^a   Tang, Doug ^a   Towle, Andrew C ^f   Walsh, Douglas S ^a   Wilkerson, Deborah ^c  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c Barr Laboratories Inc   (United States)

^d Captain James A Lovell Federal Health Care Center   (United States)

^e Barr Laboratories   (United States)

^f VaccGen International LLC   (United States)

Author keywords

Acute respiratory infection; Adenovirus Type 4; Adenovirus Type 4 and Type 7 vaccine, live, oral; Adenovirus Type 7; ADV 4; ADV 7; Live vaccines; Oral vaccine

Indexed keywords

ADENOVIRUS VACCINE; NEUTRALIZING ANTIBODY;

ABDOMINAL PAIN; ACUTE RESPIRATORY TRACT DISEASE; ADULT; ARTHRALGIA; ARTICLE; BACKACHE; BLISTER; CHILL; CONSTIPATION; CONTROLLED STUDY; COUGHING; DEHYDRATION; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; DYSPNEA; EPISTAXIS; FAINTNESS; FEMALE; FEVER; HEADACHE; HUMAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; NORMAL HUMAN; NOSE OBSTRUCTION; OTALGIA; PAIN; PERIOSTITIS; PERIPHERAL EDEMA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RHINORRHEA; SEROCONVERSION; SHOULDER PAIN; SOLDIER; THORAX PAIN; TOOTH PAIN; UNITED STATES; UPPER ABDOMINAL PAIN; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

EID: 84884701952     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.04.035     Document Type: Article

References (25)

1. Dudding B.A., Top F.H., Winter P.E., Bueschner E.L., Lamson T.H., Leibovitz A. Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971. Am J Epidemiol 1973, 97:187-198.
2. Binn L.N., Sanchez J.L., Gaydos J.C. Emergence of adenovirus 14 in US military recruits - a new challenge. J Infect Dis 2007, 196:1436-1437.
3. Kitchen L.W., Vaughn D.W. Role of U.S. military research programs in the development of U.S. licensed vaccines for naturally occurring infectious diseases. Vaccine 2007, 25:7017-7030.
4. Gaydos C.A., Gaydos J.C. Adenovirus vaccines in the U.S. military. Mil Med 1995, 160:300-304.
5. Buescher E.L. Respiratory disease and the adenoviruses. Med Clin N Am 1967, 51:769-779.
6. Chanock R.M., Ludwig W., Huebner R.J., Cate T.R., Chu L.W. Immunization by selective infections with type 4 adenovirus grown in human diploid tissue cultures. I. Safety and lack of oncogenicity and tests for potency in volunteers. JAMA 1966, 195:445-452.
7. Edmonson W.P., Purcell R.H., Gundelfinger B.F., Love J.W., Ludwig W., Chanock R.M. Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. II. Specific protective effect against epidemic disease. JAMA 1966, 195:453-459.
8. Top F.H., Grossman R.A., Bartelloni P.J., Segal H.E., Dudding B.A., Russell P.K., et al. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis 1971, 124:148-154.
9. Top F.H., Buescher E.L., Bancroft W.H., Russell P.K. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J Infect Dis 1971, 124:155-160.
10. Two fatal cases of adenovirus-related illness in previously healthy young adults, Illinois, 2000. MMWR Morb Mortal Wkly Rep 2001, 50:553-555.
11. Russell K.L., Hawksworth A.W., Ryan M.A., Strickler J., Irvine M., Hansen C.J., et al. Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004. Vaccine 2006, 24:2835-2842.
12. Lyons A., Longfield J., Kuschner R., Straight T., Binn L., Seriwatana J., et al. A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults. Vaccine 2008, 26:2890-2898.
13. Metzgar D., Osuna M., Kajon A.E., Hawksworth A.W., Irvine M., Russell K.L. Abrupt emergence of diverse species B adenoviruses at US military recruit training centers. J Infect Dis 2007, 196:1465-1473.
14. Russell K.L., Hawksworth A.W., Ryan M.A.K., Strickler J., Irvine M., Hansen C.G. Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004. Vaccine 2006, 24(15):2835-2842.
15. Metzgar D., Osuna M., Yingst S., Rakha M., Earhart K., Elyan D., et al. PCR analysis of Egyptian respiratory adenovirus isolates, including identification of species, serotypes, and coinfections. J Clin Microbiol 2005, 43:5743-5752.
16. Kajon A.E., Moseley J.M., Metzgar D., Huong H.S., Wadleigh A., Ryan M.A., et al. Molecular epidemiology of adenovirus type 4 infections in US military recruits in the postvaccination era (1997-2003). J Infect Dis 2007, 196(1):67-75.
17. Blackwelder W.C. Sample size and power for prospective analysis of relative risk. Stat Med 1993, 12:691-698.
18. Farrington C.P., Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med 1990, 9:1447-1454.
19. Koopman P.A.R. Confidence limits for the ratio of two binomial proportions. Biometrics 1984, 40:513-517.
20. Gaydos C.A., Gray G.C. Adenovirus vaccines. Vaccines 2008, 1103-1122. Elsevier, Edinburgh. 5th ed. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
21. Lee S.G., Hung P.P. Vaccines for control of respiratory disease caused by adenoviruses. Rev Med Virol 1993, 3:209-216.
22. Rose H.M., Lamson T.H., Buescher E.L. Adenovirus infection in military recruits. Arch Environ Health 1970, 21:356-361.
23. Russell K.L., Broderick M.P., Franklin S.E., Blyn L.B., Freed N.E., Moradi E. Transmission dynamics and prospective environmental sampling of adenovirus in a military recruit setting. J Infect Dis 2006, 194:877-885.
24. Stanley E.D., Jackson G.G. Spread of live adenovirus type 4 vaccine in married couples. J Infect Dis 1969, 119:51-59.
25. Mueller R.E., Muldoon R.L., Jackson G.G. Communicability of enteric live adenovirus type 4 vaccine in families. J Infect Dis 1969, 119:60-66.